From highly potent to viscous and liquid drugs, pharmaceutical producers and contract manufacturers must fill numerous medicines and suspensions into a wide variety of containers. Choosing the right filling system is crucial for efficient and safe processes. This requires a partner with a broad port…

– 100 percent IPC enables flexible redosing with maximum product yield.
– Gentle processing of up to 400 syringes per minute.
– Combination of proven technologies ensures fast availability and low risk.

Following the first virtual presentation at Interphex, Syntegon is now introducing its new filling mach…

– Räumliche Veränderungen ermöglichen weiteres Wachstum
– Fokussierter Pharma-Standort in Fellbach schafft neue Produktionskapazitäten
– Neues Business Excellence Center in Bad Cannstatt unterstützt weltweite Expansion
– Andreas Stihl AG & Co. KG übernimmt Waiblinger Liegenschaft

Syntegon, ein strategischer Partn…

The market for ready-to-use (RTU) syringes is growing rapidly. In fact, experts anticipate an annual growth rate of about eight percent over the next ten years. In response to this demand, Syntegon has expanded its inspection portfolio with the new AIM DIRect to include integrated de-nesting and re…

– RMA assembly solution for pens and autoinjectors recognized for user-friendliness and seamless processes.
– Design simplifies operations and enables flexible production.
– Long-term value for pharmaceutical manufacturers of, for example, antidiabetics and weight-control products.

Syntegon has received t…

– Eros Carletti joined Syntegon as new CFO effective January 6, 2025
– Peter Hackel resigned on December 31, 2024, after two successful years

The Syntegon Group, a strategic partner to the global pharmaceutical and food industries, has appointed Eros Carletti as new Chief Financial Officer (CFO). He joi…

– State-of-the-art facility built to boost collaboration
– Designed with the customer in mind
– Construction project completed ahead of schedule after 18 months

The leading provider of processing and packaging solutions Syntegon has completed the construction of its new office building at its Crailsheim p…

– Sustainability confirmed as key element of Syntegon’s corporate strategy
– Syntegon aims to reduce Scope 3 CO2 emissions by 25 percent, as well as Scope 1 and 2 emissions by 48.3 percent until 2030
– Lifecycle approach along the value chain: from seamless processes and innovative technologies to sust…

– Strengthening strategic growth with a seamless technology and service portfolio
– Significantly expanded pharmaceutical liquid filling offering
– Very positive customer feedback and first inquiries for joint projects

Following regulatory approval, Syntegon and Azbil Corporation have officially closed th…

Most OSD drug manufacturing companies may know the TPR tablet compression range from Syntegon. It has been part of the portfolio for exactly ten years now and is installed in many facilities around the globe. However, its history goes back a lot longer – and takes us to the origins of Manesty tabl…